Skip to main content
Sign In

Search

Note: This page will take a moment to download because of the quantity of trials.

Subscribe

Learn about the latest research trials with our daily email.
 

Feedback

Did you have problems using this page? Please fill out our Feedback Form

Clinical Trials

Volunteer to Be Part of a Research Study

Page through all School of Medicine clinical and research trials below. There are two categories:

  • Detailed Trial Descriptions, submitted by researchers, includes trial specifics and contact information.

  • Additional Clinical Trials, which include basic study details. To contact the researcher either Google the PI (primary investigator) name or use our campus directory.

If you are a researcher seeking volunteers and your study is not posted, please
submit your Web ad here.
  

Detailed Trial Descriptions

 Results From Research and Clinical Trials : Selected site
Data pager
<
>
Page Size
PageSizeComboBox
select
 |  Displaying page 1 of 5, items 1 to 30 of 135.
COMIRB Approved Advertisement TitleStudy GoalsEligibility CriteriaDate PostedCategory
Data pager
<
>
Page Size
PageSizeComboBox
select
 |  Displaying page 1 of 5, items 1 to 30 of 135.
Do you have Parkinson's Disease?
To explore the effects of different doses of endurance exercise in people with PD.​
Persons 40-80 who have been diagnosed with Parkinson's Disease and are not yet taking medication or plant to start medication within the next 6 months. You must be willing to begin the exercise program immediately or after a delay of 6 months and willing to do aerobic exercise on a treadmill.
5/27/2016 
Do you have Atopic Dermatitis (Eczema)?
To study eczema
Males and Females between 3 and 80 who have atopic dermatitis or males and females between 8 months and 80 who have a history of, or an active case of eczema hereticum (wide-spread herpes skin infection along with atopic dermatitis.
5/27/2016 
Better Control of Type 2 Diabetes May Decrease Your Risk for Cardiovascular Disease.
To look at the use of an extended release formula of Exenatide compared to a placebo to maintain normal glucose levels. Ultimately to see better control of diabetes and a decrease in cardiovascular disease events.​
Person 18+ with Type 2 Diabetes and take no more than 2 diabetes medications with stale doses for the last 3 months. Must not have a planned or anticipated revascularization procedure, but may have a history of cardiovascular disease and must see your primary care physician at least twice a year.
5/27/2016 
Type 2 Diabetes and Exercise Research Study
To research the effects of an investigational drug on exercise capacity and blood vessel function​.​
Person 30-60 with Type 2 diabetes who exercise vigorously less than one hour per week and have normal blood pressure. Must not have smoked for at least one year and have a BMI between 25-39.9.
5/27/2016 
Are you a Non-smoking Adult between the ages of 45 and 85?
We are interested in learning more about smoking related lung disease, and need healthy non-smoking participants.
45-85 years old Non-Hispanic White or African American No smoking history No evidence of lung disease
5/27/2016 
Volunteers needed to Participate in a Research Study about Rheumatoid Arthritis
The purpose of this study is to learn more about how rheumatoid arthritis develops by studying people who do not have rheumatoid arthritis. Your participation in this study will help us determine if certain genetic and environmental factors affect the chances of developing RA-related autoantibodies in absence of rheumatoid arthritis.
You may be eligible to participate in the study if: -You are at least 40 years old -You do NOT have Rheumatoid Arthritis (RA)
5/27/2016 
Restoring Insulin Secretion (RISE)
The Children’s Hospital Colorado Clinical Translational Research Center and the National Institutes of Health are conducting a study. This study is aimed at testing whether early treatment is beneficial to kids with early type 2 diabetes and kids at high risk of diabetes.
10-19 years of age, Pubertal, Overweight, Fasting glucose: >90 mg/dl; Impaired glucose tolerance: >140 mg/dl; Pre-diabetes or diagnosed with diabetes for less than 6 months; Metformin
5/27/2016 
Do You Smoke?
To figure out how these lung substances work in people who drink too much alcohol, who usually smoke, compared to those who do not drink heavily, but who smoke.
Smoking and nonsmoking males
5/27/2016 
Parents or Legal Guardians of Children with Disabilities
Assistive Technology Partners, University of Colorado, Anschutz Medical Campus, is performing a study investigating the impact Socially Assistive Robotics has on motor, communication and cognitive skills of children with disabilities.
Children between the ages of 18 months to 5 years of age Have Significant motor and communication disabilities/delays NOT been diagnosed with blindness or deafness They are without a seizure disorder or with a well-controlled seizure disorder They have been on stable medication regime for the past 12 weeks, if they are currently taking medication.
5/27/2016 
The Influence of Couples' Conversation on the Heart
The purpose of the study is to examine the influence that conversations between married couples have on the functioning of the heart.
Married Christian couples who: • Have been married for at least 1 yr. • Both believe in prayer. • Are not currently taking heart medications. • Do not have heart problems. • Are not pregnant.
5/27/2016 
Help Us Learn About Schizophrenia!
Help us learn more about a new drug that may improve thinking and concentration in people with schizophrenia.
We are looking for: Male and female adults who smoke 18-50 years old No previous or current mental illness No drug use Willing to use nicotine patch during study hospital visit If female, willing to use birth control during the study
5/27/2016 
Research Trial Evaluating a New Drug in Psoriasis: Now Enrolling
The study will evaluate an investigational drug compared to a currently approved psoriasis medication. Your participation will provide valuable information to researchers seeking new and improved therapies. You will be given either Humira, placebo, or the investigational drug for up to 28 weeks, after which you may be switched over to the active drug depending on your response.
You may be eligible to participate if 18 years of age or older and have been diagnosed with moderate to severe plaque-type psoriasis for at least 6 months.
5/27/2016 
DO YOU LIKE TO EAT? HEALTHY MEN needed to participate in a research study
Research whether age affects how fat tissue responds to 1 week of overfeeding
Men who are age 25-40 yr or 55-75 yr overweight or mildly obese sedentary to moderately active non-smokers
5/27/2016--Select a Category--
Exercise for Healthy Aging
To determine whether a high versus a moderate intensity of cardiovascular + strength training has a greater improvement on health and quality of life.
Eligibility: Men aged 50-68, no major health problems that would interfere with the ability to exercise; if diabetic, must be well-controlled on oral medications (no insulin); body mass index between 20 and 40; no current/chronic infections.
5/27/2016--Select a Category--
Do you have high blood pressure?
Study to help predict if blood pressure medications will work for you.
You may be eligible if you are an adult aged 30-80 with a diagnosis of uncontrolled essential hypertension. You must not have a history of end stage liver or renal disease, cannot be pregnant, and cannot be allergic to metoprolol.
5/27/2016Heart and Blood Diseases
Give Us a Hand
To better understand Multiple Sclerosis in children and teens.
Between the ages of 3-20 AND have Multiple Sclerosis diagnosed before 18 OR Do not have MS
5/26/2016 
Are you an African American with asthma?
 We are studying why some African American people have trouble with their asthma despite taking asthma medications.
 Children age 5-17 and non-smoking Adults age18 and older who have asthma symptoms despite asthma treatment • African American ancestry (have at least one    African American grandparent)
5/26/2016 
Peanut and Tree-Nut Allergy Research Study
The purpose of this study is to determine how the body's immune system interacts with nuts and other foods to cause allergic reaction.
6-75 years of age. Have a diagnosis of peanut and/or tree-nut allergy made by either skin test or blood tests. Have no known peanut and/or tree-nut allergy.
5/26/2016 
Do you have human growth hormone (hGH) deficiency?
Primary: To demonstrate a clinical superiority of MOD-4023 over placebo in terms of decrease in Fat Mass (FM) in adult subjects with Growth Hormone Deficiency Secondary a. To determine the efficacy of MOD-4023 over placebo in other body composition variables (such as lean body mass and waist-to-hip ratio) b. To evaluate the safety and tolerability of MOD-4023 over placebo in adult subjects with GHD c. To determine the IGF-I and IGFBP-3 serum levels
Adult men and women aged 23 to 70 years of age diagnosed with either adult or childhood onset growth hormone deficiency (GHD).
5/26/2016 
Are you a parent of a child with a developmental disability and willing to contribute to a research project to increase awareness and understanding?
The purpose of this study is to gain knowledge on the topic of everyday stressors that affect the lives of children with developmental disabilities, as well as their parents/caregivers
Are you a parent of a child with a developmental disability and willing to contribute to a research project to increase awareness and understanding?
5/26/2016 
Healthy Female Adults Needed!!!
For brain imaging research study on how the brain works with we taste sweets. Your participation could help us to develop treatments and preventive measures for anorexia nervosa and obesity
Healthy females 22 to 29 who are right-handed, free of medication with no serious medical conditions, permanent metal implants or braces/retainers, and are at a healthy body weight.
5/26/2016 
Do you have an egg allergy?
To see if taking Baked Egg Therapy vs. Oral Immunotherapy may help egg-allergic children tolerate eggs.
males and females 3 to 16 years old, with documented egg allergy, ability to make regular visits to National Jewish Health for up to 2 years.
5/26/2016 
Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)
Pitavastatin is a statin that along with diet is used for the treatment of high cholesterol. It also lowers triglyceride levels in the blood. The main purpose of this clinical trial is to see if pitavastatin can prevent heart disease and heart disease related deaths in people with HIV infection who are taking HIV medications.
This study lasts about 6 years (21 visits) and you may be eligible if: • You have HIV and are between the ages of 40 and 75. • You have been on antiretroviral therapy (ART) for at least 6 months. • You have a CD4+ cell count > 100. • You have no history of cardiovascular disease (history of heart attack or stroke, etc.). • You are not currently using a statin drug.
5/26/2016 
We are looking for Healthy Men and Women to participate in a research study to determine how Exercise Impacts Fat Metabolism During Sleep
The University of Colorado Anschutz Medical Campus is recruiting healthy men and women to participate in a research study investigating how exercise performed during the day impacts hormones and metabolism during sleep.  Adults spend about one-third of their lives sleeping yet little is known about metabolism during this period or how day time exercise influences sleeping metabolism.  Learning more about sleeping metabolism will improve our understanding of how the body regulates body weight.
This research study is looking for healthy men and women aged 20 to 35 years, who have a BMI < 30, exercise less than 3 days per week, and have a regular sleep schedule.
5/26/2016Nutritional and Metabolic Diseases
Paid Volunteers Needed for high blood pressure study
Looking for participants in clinical studies. Tests conducted to evaluate Blood Pressure devices per FDA requirements.
Subjects must be 3 years of age and have an arm circumference between 12-55cm.  Looking for healthy Adults, and Kids, non-medicated High Blood Pressure, and individuals with large arms/biceps.  Studies conducted year round on an on-going basis. Payment made on a per study basis, typical $50-100/study.
 
5/26/2016Heart and Blood Diseases
Are You a Healthy Individual Looking to Help With Research
This is a research study to learn more about the risk factors, features, and treatment or prevention efforts for bleeding disorders.
Aged 1 to 17 Healthy
5/26/2016--Select a Category--
Are you interested in participating in a research study to help us learn more about where the fat tissue in your body originates? MYTH Study
This research study plans to learn more about where the fat cells in your body come from.  Understanding the origin of fat cells is important because it may help to determine the health of fat cells and why fat that is stored in some places of your body is more "unhealthy" than other fat.
We are enrolling men and women who are: Age 21-40 y or 55-85 y; BMI 22-35 kg/m2; Weight stable (not actively gaining or trying to lose weight); Non-active to moderately active (exercise ≤ 3 days/wk lasting < 30 min); Not taking any hormonal therapy (testosterone, estrogen/progesterone replacement, or hormonal contraceptives); Not diagnosed with type 2 diabetes or taking glucose or lipid lowering medication; Not pregnant or planning to become pregnant in the next month
5/26/2016Nutritional and Metabolic Diseases
Healthy Volunteers Needed for a Drug-Drug Interaction Research Study
The study will look at the levels of dolutegravir (a HIV medication) and simeprevir (a Hepatitis C medication) in the blood when given alone and in combination.
We are looking for men and women who are: -HIV and Hepatitis C negative -Age 18-60 -Do not have chronic health conditions requiring medications, including but not limited to, high blood pressure, diabetes, eczema, or psoriasis -Not taking any medications except aspirin, Tylenol, ibuprofen, or oral contraceptives
5/26/2016--Select a Category--
Research study on the effects of an investigational drug on weight and neuronal response
This research study plans to examine the effects of an investigational new drug on neuronal, physiological, and behavioral mechanisms of obesity in the general population.
To be eligible for the study, participants must have a BMI greater than 27 kg/m2, be 21-65 years old, be a non-smoker, have no known cardiovascular disease, have no significant endocrine/metabolic disease, must not be pregnant or trying to conceive, and must be able to complete an MRI scan.
5/26/2016Behaviors and Mental Disorders
Investigations in Gestational Origins of Lifetime Development: Understanding health begins before birth. Are you in your first trimester of Pregnancy?
To learn more about how your metabolism is connected to your baby's growth and development
  • Healthy Women ages 18-35 who are 10-14 weeks pregnant with single baby.  With a  BMI of 30-38 who are willing to complete 5 visits during pregnancy and agreeable to an infant blood draw at birth and DXA postpartum.  
There is an option to take part in a 1 year follow-up which entails an additional 4 visits and another DXA at 1 year of life.
5/25/2016 

​Additional Clinical Trails

 Results From Research : Selected site
Data pager
<
>
Page Size
PageSizeComboBox
select
 |  Displaying page 1 of 41, items 1 to 30 of 1220.
Protocol TitlePI NameInstitution Number
Data pager
<
>
Page Size
PageSizeComboBox
select
 |  Displaying page 1 of 41, items 1 to 30 of 1220.
DENVER FOLLOW-UP AT CHILD AGE 6 OF NURSE AND PARAPROFESSIONAL HOME VISITING FOR MOTHER'S AND CHILDREN
Olds, David L Ph.D.00-036
IMMUNOHISTOCHEMICAL AND PCR-BASED CHARACTERIZATION OF ARCHIVAL SURGICAL PATHOLOGY SPECIMENS
Thor, Ann Denise MD00-1094
CCG-1991-ESCALATING DOSE INTRAVENOUS METHOTREXATE WITHOUT LEUCOVORIN RESCUE VS. ORAL METHOTREXATE AND SINGLE VS DOUBLE DELAYED INTENSIFICATION THERAPY FOR CHILDREN WITH STANDARD RISK ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Garrington, Timothy P M.D.00-583
COG-P9645: INTERGROUP PROTOCOL FOR TREATMENT OF CHILDREN WITH HEPATOBLASTOMA
Greffe, Brian S01-112
THE ROLE OF PLATELET ACTIVATING FACTOR-LIKE LIPIDS IN PATIENTS WITH TRANSFUSION RELATED ACUTE LUNG INJURY
Silliman, Christopher M.D.01-196
COG-ANBL00B1 NEUROBLASTOMA BIOLOGY STUDIES
Greffe, Brian S01-209
COG-A3973: A RANDOMIZED STUDY OF PURGED VERSUS UNPURGED PERIPHERAL BLOOD STEM CELL TRANSPLANT FOLLOWING DOSE INTENSIVE INDUCTION THERAPY FOR HIGH RISK NEUROBLASTOMA
Greffe, Brian S01-210
AMERICAN INDIAN CHILD DEVELOPMENT & ATTACHMENT
Sarche, Michelle Christensen01-233
A STUDY OF THE EFFECTIVENESS AND TOLERABILITY OF WEEKLY RIFAPENTINE/ISONIAZID FOR THREE MONTHS VERSUS DAILY ISONIAZID FOR NINE MONTHS FOR THE TREATMENT OF LATENT TUBERCULOSIS INFECTION [TBTC STUDY 26]
Gardner, Edward M M.D.01-284
GENETIC STUDIES OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Gitomer, Berenice Y Ph.D.01-286
Pathogenic and Regulatory T and B Cell Responses in Type 1 Diabetes and Other Autoimmune Diseases
Gottlieb, Peter Ashley M.D.01-384
CHOLESTEROL AND ANTIOXIDANT TREATMENT IN PATIENTS WITH THE SMITH-LEMLI-OPITZ SYNDROME (SLOS)
Elias, Ellen Roy M.D.01-410
CONTINUATION OF CHILDREN ENROLLED IN PROTOCOL #95-11, "A RANDOMIZED PROSPECTIVE STUDY FOR THE PREVENTION OF JOINT DISEASE IN CHILDREN WITH SEVERE FACTOR VIII DEFICIENCY."
Manco-Johnson, Marilyn M.D.01-436
EFFECTS OF PRENATAL NICOTINE EXPOSURE AND A PARENTAL HISTORY FOR SCHIZOPHRENIA ON SACCADIC EYE MOVEMENT PARAMETERS IN INFANTS
Ross, Randal G MD01-561
AGRICULTURE, MATERNAL-INFANT NUTRITION & PUBLIC HEALTH PROYECTO MADRES DE MAIZ
Hambidge, K Michael01-596
ANBL0032 PHASE III RANDOMIZED STUDY OF CHIMERIC ANTIBODY 14.18 (CH 14.18) IN HIGH RISK NEUROBLASTOMA FOLLOWING MYELOABLATIVE THERAPY AND AUTOLOGOUS STEM CELL RESCUE
Greffe, Brian S01-932
SEARCH FOR DIABETES IN YOUTH
Dabelea, Dana M. MD, PhD01-934
ALOPECIA AREATA REGISTRY AND IMMUNOGENETIC MECHANISMS
Norris, David A02-043
P9851 OSTEOSARCOMA BIOLOGY PROTOCOL
Garrington, Timothy P M.D.02-080
AEWS0031 TRIAL OF CHEMOTHERAPY INTENSIFICATION THROUGH INTERVAL COMPRESSION IN EWING SARCOMA AND RELATED TUMORS
Garrington, Timothy P M.D.02-081
SURVEILLANCE OF THE RADARS SYSTEM BY POISON CONTROL CENTERS.
Dart, Richard C02-139
CELIAC DISEASE IN TYPE I DIABETES: GROWTH AND BONE MINERALIZATION
Frohnert, Brigitte I M.D, PhD02-175
PACTG P1025: PERINATAL CORE PROTOCOL
McFarland, Elizabeth J M.D.02-294
QUALITY OF LIFE IN SURVIVORS OF CHILDHOOD BRAIN TUMORS: A FOLLOW-UP STUDY
Foreman, Nicholas K MD02-301
CYSTIC FIBROSIS FOUNDATION NATIONAL PATIENT REGISTRY
Sagel, Scott D MD, PhD02-349
ANBL00P2 PERINATAL NEUROBLASTOMA: EXPECTANT OBSERVATION
Greffe, Brian S02-390
FOSTERING HEALTHY FUTURES STUDY
Taussig, Heather N PhD02-516
EFFICACY OF AGGRESSIVE RENIN-ANGIOTENSIN-ALDOSTERONE AXIS BLOCKADE IN PREVENTING/SLOWING RENAL FUNCTION DECLINE IN ADPKD
Schrier, Robert W02-744
THE ACUTE CHEST SYNDROME IN SICKLE CELL ANEMIA: THE ROLL OF THE NEUTROPHIL
Silliman, Christopher M.D.02-749
SEARCH-CC
Dabelea, Dana M. MD, PhD02-825


Contact Us

Building 500 - 13001 E. 17th Place, Campus Box C290, Aurora, CO 80045

Learn more